6 Minute Read
This month, we offer commentary on two topics around Direct-to-Patient and the Impact of Maximum Fair Prices on the First 10 Medicare-Negotiated Drugs.
3 Minute Read
Keep up-to-date on Branded Prescription Drug Fees with this summary of critical insights from Nick Lynch, Partner at IntegriChain, covering key deadlines and factors.
4 Minute Read
The pharmaceutical industry is facing unprecedented challenges as market access dynamics continue to evolve. To navigate these complexities, companies must rethink channel, pricing, contracting, and patient access strategies.
4 Minute Read
In this blog, we recap the key insights shared by Nick Lynch, Partner at IntegriChain, and Suriya Janarthanan, Associate Director at Novartis, on how manufacturers can navigate FMV and...
2 Minute Read
In today’s rapidly evolving pharmaceutical landscape, creating an effective commercial data strategy is critical for achieving success.
2 Minute Read
The pharmaceutical industry faces increasing difficulty accurately calculating and reporting government prices due to stringent regulations and recent complex changes.
4 Minute Read
Independent pharmacies are struggling due to the Inflation Reduction Act (IRA), which increases drug costs and tightens payer restrictions, affecting their finances. The 340B program, meant to aid low-income...
2 Minute Read
Efficient inventory management is crucial for healthcare organizations to ensure patient satisfaction, maintain financial stability, and mitigate supply chain risks. Moving forward, drug manufacturers must adapt their inventory management...
4 Minute Read
As the industry approaches full compliance with DSCSA requirements, new challenges emerge, particularly in managing data discrepancies, addressing inventory exceptions, and navigating gross-to-net impacts.